Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05575466
Other study ID # 85860
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 15, 2022
Est. completion date November 30, 2026

Study information

Verified date December 2022
Source Odense University Hospital
Contact Jeanie Meincke Egedal, MD
Phone 004522719127
Email jeaniemeinckeegedal@gmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

BACKGROUND: Sudden death due to thromboembolic (TE) events in patients with anorexia nervosa (AN) is well known. However, the incidence of TE events and the hemostatic balance in patients with AN are sparsely investigated. Also, associations between re-nutrition and the hemostatic balance have not been studied. OBJECTIVE: To describe the incidence of TE events in patients with AN compared to the background population, to characterize the hemostatic balance in AN compared to normal-weight women, and to assess the associations between the hemostatic balance and nutritional status, insulin sensitivity and cortisol level in women with AN. METHODS: The incidence of TE will be described using a Danish cohort of AN patients (n=10,049) with follow-up in national registries. A comprehensive battery of hemostatic biomarkers will be compared in a case-control study of 40 patients with AN and associations between hemostasis and nutritional status will be studied.


Description:

BACKGROUND Anorexia nervosa (AN) is a complex psychiatric disorder with concomitant medical complications to malnutrition and starvation and it is associated with the highest mortality of the mental illnesses. It is estimated that one-third of all deaths in patients with AN are due to cardiac causes, mainly sudden death, and alterations in cardiac electrical activity, structure and hemodynamics have been suggested as mortality causes. Thrombotic disorders such as myocardial infarction, stroke, and pulmonary embolism may also result in sudden cardiac death, and the investigators have previously reported venous thromboembolism in four patients with AN Whether a disturbed hemostatic balance is associated with re-nutrition, insulin sensitivity and cortisol in AN is unknown. The guidelines of thromboprophylaxis treatment may not be appropriate in this patient group due to metabolic and hemostatic disturbances and increased thrombotic risk of reasons related to refeeding syndrome not listed in current guidelines. To optimize guidelines for AN patients, new evidence is highly warranted AIMS This study aims to determine the incidence of venous and arterial thromboembolic events in patients with AN compared to the background population, to characterize the hemostatic balance in AN compared to normal-weight women, and to assess the associations between the hemostatic balance and nutritional status, insulin sensitivity and cortisol level in women with AN. The study will provide new knowledge which qualifies the work of preparing guidelines for thrombosis prophylactic intervention in this patient group. RESEARCH QUESTIONS 1. Is the incidence of venous and arterial thromboembolism increased in patients diagnosed with AN compared to an age-matched control group? 2. Is the hemostatic balance disturbed in women with AN compared with healthy, normal-weight women? 3. Are cortisol, insulin sensitivity and nutritional status associated with alterations in biomarkers of the hemostatic balance in AN? The research questions will be answered in three sub studies. SUB STUDY 1 Sub study 1 will answer research question 1, determining if the incidence of venous and arterial thromboembolism is increased in patients with AN compared to an age-matched control group. The study is based on the comprehensive Danish registries. An already existing cohort of more than 10,000 patients with AN will be evaluated for incidence of thromboembolic events and compared to an age-matched control group. SUB STUDY 2 Sub study 2 will answer research question 2, exploring the hemostatic balance in patients with AN compared to healthy, normal-weight controls. Patients with anorexia nervosa (n=40) will be recruited from the highly specialized Center of Eating Disorders at Odense University Hospital. Patients and controls will have blood samples drawn to evaluate the hemostatic balance using a large battery of hemostatic markers. SUB STUDY 3 Sub study 3 will answer research question 3, clarifying associations between the hemostatic balance and cortisol, insulin sensitivity and nutritional status in AN. Participants of sub study 3 are the patients with AN from sub study 2. From further analysis of the blood samples and by answering validated questionnaires to determine nutritional status and AN severity, research question 3 will be answered.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date November 30, 2026
Est. primary completion date December 31, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria, patients: - Fulfilling Diagnostic and Statistical Manual V (DSM-5) criteria for AN - Age 18 - 50 years - Female sex Exclusion Criteria, patients: - Somatic comorbidity requiring systemic medications - Previous thromboembolic event and/or known genetic predisposition - Use of p.o. hormonal contraception - Smoking Inclusion Criteria, controls: - BMI 18.5 - 25.0 - Age 18 - 50 years - Female sex Exclusion Criteria, controls: - Somatic comorbidity requiring systemic medications - Previous thromboembolic event and/or known genetic predisposition - Use of p.o. hormonal contraception - Smoking

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Blood samples
Hemostatic biomarkers
Questionnaires
Eating Disorder Inventory - third version (EDI-3) Eating Disorder Quality of Life Scale (EDQLS)

Locations

Country Name City State
Denmark Unit for Thrombosis Research, Department of Clinical Biochemistry, Hospital of South West Jutland Esbjerg Jylland
Denmark Clinical Pharmacology and Pharmacy, University of Southern Denmark Odense Fyn
Denmark Department of Child and Adolescent Mental Health Odense, Mental Health Services in the Region of Southern Denmark Odense Fyn
Denmark The Nutritional Unit, Department of Endocrinology, Center for Eating Disorders, Odense University Hospital and Psychiatry in the region of Southern Denmark Odense Fyn
Sweden Department of Clinical Sciences, Umeå University Umeå Västerbotten

Sponsors (1)

Lead Sponsor Collaborator
Odense University Hospital

Countries where clinical trial is conducted

Denmark,  Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other Hemostatic balance Evaluation of differences of measurements of hemostatic biomarkers in patients with AN compared to healthy controls.
Hemostatic biomarkers that will be evaluated:
Tissue factor TF:Ag, pg/mL
Contact activation (descriptive, system is assessed)
Fibrinogen mg/dl
Thrombin generation (descriptive)
Prothrombin fragment 1+2 pmol/L
Plasminogen activator inhibitor type 1 ng/mL
Tissue plasminogen activator ng/mL
Fibrin clot properties (descriptive, using turbidity measurements)
The study is cross-sectional. Time frame for completion of participation in the study is 1 day.
Other Rotational Thromboelastometry (ROTEM)-variables Evaluation of differences in ROTEM-variables in patients with AN compared to healthy controls. The study is cross-sectional. Time frame for completion of participation in the study is 1 day.
Primary Incidence of thromboembolic events Arterial and venous thrombosis. Non-fatal outcomes of a thromboembolic event will be validated by the use of anticoagulants in the period immediately after the outcome defining event. Data on thromboembolic events are collected from health registries. Data is collected through study completion of the time frame in the registry, up to 26 years.
See also
  Status Clinical Trial Phase
Recruiting NCT05531604 - Appetitive Conditioning in Anorexia Nervosa
Enrolling by invitation NCT04174703 - Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing N/A
Active, not recruiting NCT04883554 - Impact of an Olfactory Sensory Therapeutic Group for Adolescent Patients With Restrictive Anorexia Nervosa , Pilot Study N/A
Recruiting NCT04213820 - TMS and Body Image Treatment for Anorexia Nervosa N/A
Completed NCT03414112 - The Impact of Oxytocin on the Neurobiology of Anorexia Nervosa Early Phase 1
Recruiting NCT06144905 - Norwegian Microbiota Study in Anorexia Nervosa
Recruiting NCT05803707 - Home-based Adapted Physical Activity in Anorexia Nervosa: a Feasibility Pilot Study N/A
Recruiting NCT05682417 - Impact of Body Schema Distortion on Remission and Weight Regain in Anorexia Nervosa N/A
Not yet recruiting NCT06380257 - Anorexia Nervosa and Brain in Adolescence
Not yet recruiting NCT04804800 - Virtual Reality Place in the Management of Body Dysmorphia Disorders in Anorexia Nervosa N/A
Not yet recruiting NCT03600610 - Evaluation of CARdiac Abnormalities by Echocardiography and MRI in Malnourished Patients Suffering From Anorexia Nervosa N/A
Completed NCT02745067 - Effectiveness of Enhanced Cognitive Behavioral Therapy (CBT-E) in the Treatment of Anorexia Nervosa N/A
Completed NCT02382055 - Changing Habits in Anorexia Nervosa: Novel Treatment Development N/A
Terminated NCT02240797 - Kappa Opioid Receptor Imaging in Anorexia N/A
Completed NCT03075371 - Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa N/A
Completed NCT03144986 - Insula-coil Deep TMS for Treatment Resistant Anorexia Nervosa N/A
Unknown status NCT01761942 - Fatty Acids Omega -3 Diet Supplementation Efficiency and Safety Evaluation in Anorexia Nervosa Phase 2
Completed NCT02551445 - A fMRI Pilot Study of the Effects of Meal-support in Eating Disorders. N/A
Completed NCT01579682 - Adaptive Family Treatment for Adolescent Anorexia Nervosa N/A
Completed NCT00946816 - The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity N/A